U.S., Jan. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07323563) titled 'A Study to Assess Nicotine Uptake From Electronic Nicotine Delivery Systems' on Dec. 22, 2025.
Brief Summary: This will be an open-label, randomized, single-site, 8-way crossover study designed to evaluate plasma nicotine pharmacokinetic (PK) parameters and overall product liking (OPL) following an ad libitum use of Electronic Nicotine Delivery System (ENDS) investigational products (IPs) in a confinement setting by generally healthy adult combustible cigarette smokers and smokers who also use ENDS products.
Study Start Date: March 15
Study Type: INTERVENTIONAL
Condition:
Smoking
Smoking Behaviors
Tobacco Use
Tobacco Smoking
Int...